Recursion to Host Webinar on Tupelo Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis on Dec. 8
RefinitivLess than 1 min read
Recursion Pharmaceuticals Inc 
RXRX:
RECURSION ANNOUNCES WEBINAR FOR UPCOMING CLINICAL DATA READOUT ON THE TUPELO PHASE 1B/2 TRIAL OF REC-4881 IN FAMILIAL ADENOMATOUS POLYPOSIS ON DECEMBER 8, 2025
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Login or create a forever free account to read this news